Trevor Hallam, Chief Science Officer at SUTRO BIOPHARMA, INC. (STRO), sold 975 shares at $9.69 ($9K) on 2020-03-26, disclosed to the SEC on 2020-03-27.
Scheduled sale ($9k) by Chief Science Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| STRO | SELL | 2020-11-30 | $41K | — | Filing → |
| STRO | SELL | 2020-11-06 | $251K | — | Filing → |
| STRO | SELL | 2020-09-28 | $10K | — | Filing → |